Aperio Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $74M | Buy |
1,082,723
+46,675
| +5% | +$3.04M | 0.22% | 74 |
|
|
2020
Q3 | $60.5M | Sell |
1,036,048
-9,187
| -0.9% | -$572K | 0.2% | 86 |
|
|
2020
Q2 | $67.9M | Buy |
1,045,235
+57,657
| +6% | +$3.63M | 0.25% | 71 |
|
|
2020
Q1 | $58.6M | Buy |
987,578
+24,912
| +3% | +$1.66M | 0.26% | 67 |
|
|
2019
Q4 | $71.5M | Buy |
962,666
+48,173
| +5% | +$3.38M | 0.26% | 69 |
|
|
2019
Q3 | $57.7M | Buy |
914,493
+222,346
| +32% | +$13.2M | 0.23% | 81 |
|
|
2019
Q2 | $37.7M | Buy |
692,147
+154,689
| +29% | +$8.33M | 0.15% | 140 |
|
|
2019
Q1 | $29M | Sell |
537,458
-420,235
| -44% | -$25.9M | 0.13% | 179 |
|
|
2018
Q4 | $62.7M | Buy |
957,693
+283,620
| +42% | +$21.2M | 0.32% | 60 |
|
|
2018
Q3 | $53.1M | Buy |
674,073
+45,859
| +7% | +$3.28M | 0.23% | 88 |
|
|
2018
Q2 | $40.4M | Buy |
628,214
+31,185
| +5% | +$2.06M | 0.19% | 120 |
|
|
2018
Q1 | $37.1M | Sell |
597,029
-43,831
| -7% | -$3.14M | 0.18% | 122 |
|
|
2017
Q4 | $46.5M | Sell |
640,860
-172,487
| -21% | -$12.5M | 0.24% | 91 |
|
|
2017
Q3 | $66.1M | Buy |
813,347
+60,058
| +8% | +$4.75M | 0.37% | 52 |
|
|
2017
Q2 | $60.6M | Buy |
753,289
+42,157
| +6% | +$3.33M | 0.37% | 47 |
|
|
2017
Q1 | $55.8M | Buy |
711,132
+213,343
| +43% | +$17M | 0.38% | 44 |
|
|
2016
Q4 | $39.3M | Sell |
497,789
-280,709
| -36% | -$22.7M | 0.3% | 67 |
|
|
2016
Q3 | $69.3M | Buy |
778,498
+5,381
| +0.7% | +$508K | 0.5% | 35 |
|
|
2016
Q2 | $74M | Buy |
773,117
+27,196
| +4% | +$2.71M | 0.58% | 26 |
|
|
2016
Q1 | $77.4M | Buy |
745,921
+28,013
| +4% | +$2.72M | 0.66% | 19 |
|
|
2015
Q4 | $70.2M | Sell |
717,908
-10,854
| -1% | -$1.06M | 0.64% | 22 |
|
|
2015
Q3 | $70.3M | Buy |
728,762
+45,212
| +7% | +$4.75M | 0.72% | 15 |
|
|
2015
Q2 | $71.7M | Buy |
683,550
+31,456
| +5% | +$3.21M | 0.74% | 13 |
|
|
2015
Q1 | $67.3M | Buy |
652,094
+54,893
| +9% | +$5.55M | 0.75% | 11 |
|
|
2014
Q4 | $57.5M | Buy |
597,201
+53,580
| +10% | +$4.72M | 0.71% | 13 |
|
|
2014
Q3 | $43.3M | Buy |
543,621
+57,549
| +12% | +$4.54M | 0.58% | 22 |
|
|
2014
Q2 | $36.6M | Buy |
486,072
+61,190
| +14% | +$4.62M | 0.53% | 26 |
|
|
2014
Q1 | $31.8M | Buy |
+424,882
| New | +$30M | 0.45% | 25 |
|
|
2013
Q4 | – | Sell |
-289,087
| Closed | -$18.6M | – | 33 |
|
|
2013
Q3 | $16.4M | Buy |
289,087
+36,170
| +14% | +$2.16M | 0.32% | 55 |
|
|
2013
Q2 | $14.5M | Buy |
+252,917
| New | +$14.7M | 0.34% | 46 |
|
Other funds holding CVS
Aperio Group's CVS Position: Q4 2020 in Review
Aperio Group increased its CVS Health (CVS) stake by 4.5% in Q4 2020, buying an estimated $3.04M and bringing the position to 1,082,723 shares worth $74M. The position accounts for 0.22% of the portfolio, ranked #74.
Aperio Group first reported a position in CVS in Q2 2013 and has held it in 30 quarters since. The position peaked at $77.4M in Q1 2016. 1,973 funds tracked by Wall St. Rank hold CVS as of Q4 2020.
- Aperio Group held 1,082,723 shares of CVS Health worth $74M as of Q4 2020.
- Aperio Group bought 46,675 CVS Health shares in Q4 2020, an estimated $3.04M.
- CVS Health made up 0.22% of Aperio Group's portfolio in Q4 2020, its #74 holding.
- Aperio Group first reported a position in CVS Health in Q2 2013 and has held it in 30 quarters since.
- Aperio Group's CVS Health position peaked at $77.4M in Q1 2016.
- 1,973 funds tracked by Wall St. Rank held CVS Health as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.